Welcome to the inaugural MENAHTA Forum – The pioneering conference in the UAE enabling HTA excellence for regulatory, market access, pricing and commercial life sciences experts
- 00Day(s)
- 00Hour(s)
- 00Minute(s)
- 00Second(s)
Event Overview
Welcome to the MENAHTA Forum – Your gateway to unlocking the potential of Health Technology Assessment (HTA) activities in the MENA region. Join us for an enlightening event designed to educate and empower pharmaceutical industry decision-makers and distributors on the intricacies of HTA implementation in the MENA region. Discover how HTA will shape the future of healthcare in the MENA region and learn how you can drive success for your portfolio in this transformational time for the industry.
The forum will take place on the 5th of June, 2024, at Le Méridien Hotel & Conference Centre Dubai, UAE. Register now to secure your spot and gain invaluable insights to elevate your expertise on HTA systems and support your market access strategy in the MENA region.
Key Benefits
Discover Success
Discover case studies and real-world examples illustrating successful HTA implementation strategies
Develop a HTA Toolkit
Develop actionable plans and strategies to effectively navigate the evolving landscape of healthcare technology evaluation and adoption
Understand HTA activities in MENA
Understand the role of HTA in optimizing healthcare resource allocation and decision-making in the Middle Eastern market.
Learn from Experts
Engage in interactive discussions and Q&A sessions with HTA experts to address specific challenges and opportunities
Gain a Competitive Edge
Access resources and tools to enhance your organization's HTA capabilities and competitive advantage
Gain Live Insights
Stay informed on the ongoing regulatory updates and policy changes affecting the HTA implementation
Who Should Attend
Pharmaceutical Industry Professionals
Pharmaceutical industry professionals seeking to stay ahead of industry trends and regulatory changes
Distributors and Wholesalers
Distributors and wholesalers eager to understand how HTA will impact product development and market access strategies
Key Speakers
Dr. Hussain Al-Omar
Associate Professor of Pharmacoeconomics at King Saudi University
Dr. Mohamed Farghaly
Consultant & Advisor for Health Insurance System, Dubai Health Insurance Corporation, Dubai Health Authority, EJADAH Program Lead
Lavni Varyani
Founding Partner, Pharma BP, Regional Market Access Expert
Angela Acosta
Principal Consultant, Pharma BP
Mohamed Tannira
HTA, HEOR & RWE Professional, Abbvie
Nermeen Ashoush
Health Economics & Outcomes Research Associate Director, Amgen
Stephanie Chaccour
GCC Head of Market Access & Diagnostics Rare Diseases, AstraZeneca
Dr. Abeer Al Rabayah
Health Technology Assessment Expert, Head, Center for Drug Policy and Technology Assessment at KHCC